Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03282097 · ClinicalTrials.gov registry record · NA
Decisions About Cancer Screening in Alzheimer's Disease
A NA study of Alzheimer Disease and Cancer, Breast, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 442
- Enrollment target
- 5
- Study locations
NCT03282097: Completed NA study of Alzheimer Disease and Cancer, Breast, sponsored by Indiana University.
NCT03282097 is a NA study of Alzheimer Disease and Cancer, Breast that has completed, run by Indiana University. The registered enrollment target is 442 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03282097, a NA study of Alzheimer Disease and Cancer, Breast, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 442 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Decisions about Cancer screening in Alzheimer's Disease (DECAD) study tests if an evidence-based decision aid for dementia caregivers can support decision-making about mammography and improve the quality of medical decision-making about breast cancer screening. This large randomized controlled trial will recruit up to 450 dyads (900 individual participants) of older women with dementia and a family caregiver, for a goal of 426 dyad baselines (852 individual participants).
Primary Outcome
The Decisional Conflict Scale (DCS) includes 16-items on a 1-5 Likert scale. Questions are regarding a medical decision that participants have made or that they are about to make; it measures uncertainty around a decision, whether one feels informed, clear about their personal values, and supported in their decision-making It is a validated and widely accepted measure of decision quality that has been used in previous studies of decision aids intended for AD caregivers. Scores can range from 0-1
Conditions Studied
Interventions
- BEHAVIORAL DECAD decision aid
- OTHER Home safety guide
Study Locations (5)
Indiana
- Parkview Health - Fort Wayne
- Alzheimer's Association - Indianapolis
- Eskenazi Health - Indianapolis
- IU Health - Indianapolis
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
What the finished NCT03282097 record still lists
NCT03282097 is an interventional study that assigns participants to a tested intervention. The registered 442 participants enrollment target is mid-sized for trials with a published cap, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which DECAD decision aid is the first listed.
NCT03282097 lists 5 locations in 2 states (Indiana, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03282097 about?
NCT03282097 is a clinical study titled "Decisions About Cancer Screening in Alzheimer's Disease". The Decisions about Cancer screening in Alzheimer's Disease (DECAD) study tests if an evidence-based decision aid for dementia caregivers can support decision-making about mammography and improve the quality of medical decision-making about breast cancer screening. This large randomized controlled t...
What is the current status of trial NCT03282097?
This trial is currently completed. It is a NA study. The enrollment target is 442 participants. The study started on 2017-12-01. Estimated completion is 2024-07-01.
What conditions does trial NCT03282097 study?
This clinical trial studies the following conditions: Alzheimer Disease, Cancer, Breast.
What interventions are being tested in trial NCT03282097?
The interventions under investigation include: DECAD decision aid (BEHAVIORAL), Home safety guide (OTHER).
Who is sponsoring clinical trial NCT03282097?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03282097 being conducted?
This trial has 5 study locations across Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03282097's enrollment target sits among peer trials
442 60th of 306 higher than 247 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- NCT06659029 · 442 participants
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI